搜索临床试验以:PD-1抑制剂
总计65067个结果
-
Aga Khan UniversityUniversity of British Columbia; Canadian Institutes of Health Research (CIHR)招聘中
-
Henan Cancer HospitalThe Pregene (ShenZhen) Biotechnology Company, Ltd.未知
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Pfizer; The Leukemia and Lymphoma Society终止
-
Jonsson Comprehensive Cancer CenterBayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)终止I期乳腺癌 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 浸润性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 孕激素受体阳性 | III期乳腺癌 | 绝经后 | 多灶性乳腺癌美国
-
University Hospital, Basel, SwitzerlandGMP network of Basel完全的
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Fujian Cancer Hospital; Second... 和其他合作者招聘中
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
The First Affiliated Hospital of Guangzhou Medical...未知
-
Tianjin Medical University Cancer Institute and...未知
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation Inc完全的乳腺癌 | 激素受体阳性 | Her2-正常 | 使用 CDK 4/6 抑制剂进行新辅助治疗后 | CPS-EG评分美国, 澳大利亚, 奥地利, 加拿大, 法国, 德国, 爱尔兰, 日本, 大韩民国, 西班牙, 英国
-
Calico Life Sciences LLCAbbVie招聘中
-
Jules Bordet Institute完全的
-
Pfizer完全的Healthy, Hepatic Insufficiency美国
-
Sun Yat-sen UniversityFudan University; Liaoning Tumor Hospital & Institute主动,不招人
-
Sichuan Cancer Hospital and Research Institute招聘中
-
VA Office of Research and DevelopmentUniversity of Michigan完全的
-
Wei JiangWuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital...完全的
-
Hassane M. Zarour, MDMerck Sharp & Dohme LLC; Melanoma Research Alliance完全的
-
Sichuan UniversityChengdu Brilliant Pharmaceutical Co., Ltd.尚未招聘
-
Johannes Gutenberg University MainzMerck KGaA, Darmstadt, Germany完全的
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.终止